My NCBI | Sign In
RSS Settings
  • Search: Bonora Stefano[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 61

    1.

    Magnetic-silica based nucleic acid extraction for Human Immunodeficiency Virus Type-1 drug-resistance testing in low viremic patients.

    Milia MG, Allice T, Gregori G, Mussino S, Orofino G, Bonora S, Ghisetti V.

    J Clin Virol. 2009 Nov 13. [Epub ahead of print]PMID: 19914863 [PubMed - as supplied by publisher]Related articles

    2.

    Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting.

    Calcagno A, Bonora S, Tettoni MC, D'Avolio A, Perri GD, Lanzafame M, Penco G.

    J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):431-2. No abstract available. PMID: 19858926 [PubMed - indexed for MEDLINE]Related articles

    3.

    Generation of 8.5-fs pulses at 1.3 microm for ultrabroadband pump-probe spectroscopy.

    Brida D, Bonora S, Manzoni C, Marangoni M, Villoresi P, De Silvestri S, Cerullo G.

    Opt Express. 2009 Jul 20;17(15):12510-5.PMID: 19654652 [PubMed]Related articles

    4.

    Lack of interaction between raltegravir and cyclosporin in an HIV-infected liver transplant recipient.

    Di Biagio A, Rosso R, Siccardi M, D'Avolio A, Bonora S, Viscoli C.

    J Antimicrob Chemother. 2009 Oct;64(4):874-5. Epub 2009 Jul 29. No abstract available. PMID: 19643773 [PubMed - in process]Related articles

    5.

    [HIV infection: treatment of naive patients]

    Bonora S, Calcagno A, Di Perri G.

    Infez Med. 2009 Jun;17(2):69-81. Review. Italian. PMID: 19602919 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients.

    Saracino A, Monno L, Tartaglia A, Tinelli C, Seminari E, Maggiolo F, Bonora S, Rusconi S, Micheli V, Lo Caputo S, Lazzaroni L, Ferrara S, Ladisa N, Nasta P, Parruti G, Bellagamba R, Forbici F, Angarano G.

    Curr HIV Res. 2009 Jul;7(4):425-33.PMID: 19601778 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy of early pegylated interferon alpha-2b monotherapy for acute hepatitis C in HIV-infected patients.

    De Rosa FG, Mollaretti O, Audagnotto S, De Blasi T, Cariti G, Marucco DM, Bonora S, Perri GD.

    Clin Infect Dis. 2009 Jun 1;48(11):1636-7. No abstract available. PMID: 19416030 [PubMed - indexed for MEDLINE]Related articles

    8.

    Interactions between antiretroviral agents and those used to treat tuberculosis.

    Bonora S, Di Perri G.

    Curr Opin HIV AIDS. 2008 May;3(3):306-12.PMID: 19372983 [PubMed - in process]Related articles

    9.

    Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation.

    Bonora S, Nicastri E, Calcagno A, Gonzalez de Requena D, D'Ettorre G, Sarmati L, Palmisano L, Vullo V, Di Perri G, Andreoni M.

    J Med Virol. 2009 Mar;81(3):400-5.PMID: 19152404 [PubMed - indexed for MEDLINE]Related articles

    10.

    Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis.

    Gatti F, Nasta P, Loregian A, Puoti M, Matti A, Pagni S, de Requena DG, Prestini K, Parisi SG, Bonora S, Palù G, Carosi G.

    J Antimicrob Chemother. 2009 Mar;63(3):575-8. Epub 2009 Jan 16.PMID: 19151039 [PubMed - indexed for MEDLINE]Related articles

    11.

    Molecular typing of Mycobacterium bovis strains isolated in Italy from 2000 to 2006 and evaluation of variable-number tandem repeats for geographically optimized genotyping.

    Boniotti MB, Goria M, Loda D, Garrone A, Benedetto A, Mondo A, Tisato E, Zanoni M, Zoppi S, Dondo A, Tagliabue S, Bonora S, Zanardi G, Pacciarini ML.

    J Clin Microbiol. 2009 Mar;47(3):636-44. Epub 2009 Jan 14.PMID: 19144792 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

    Svicher V, Alteri C, D'Arrigo R, Laganà A, Trignetti M, Lo Caputo S, Callegaro AP, Maggiolo F, Mazzotta F, Ferro A, Dimonte S, Aquaro S, di Perri G, Bonora S, Tommasi C, Trotta MP, Narciso P, Antinori A, Perno CF, Ceccherini-Silberstein F.

    Antimicrob Agents Chemother. 2009 Jul;53(7):2816-23. Epub 2009 Jan 5.PMID: 19124665 [PubMed - indexed for MEDLINE]Related articles

    13.

    Even-order aberration cancellation in quantum interferometry.

    Bonato C, Sergienko AV, Saleh BE, Bonora S, Villoresi P.

    Phys Rev Lett. 2008 Dec 5;101(23):233603. Epub 2008 Dec 2.PMID: 19113552 [PubMed]Related articles

    14.

    Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir.

    Siccardi M, D'Avolio A, Baietto L, Gibbons S, Sciandra M, Colucci D, Bonora S, Khoo S, Back DJ, Di Perri G, Owen A.

    Clin Infect Dis. 2008 Nov 1;47(9):1222-5.PMID: 18831695 [PubMed - indexed for MEDLINE]Related articles

    15.

    An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients.

    D'Avolio A, Baietto L, Siccardi M, Sciandra M, Simiele M, Oddone V, Bonora S, Di Perri G.

    Ther Drug Monit. 2008 Dec;30(6):662-9.PMID: 18824956 [PubMed - indexed for MEDLINE]Related articles

    16.

    Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphism.

    Garcia-Diaz A, Blok C, Madge S, Booth C, Tyrer M, Bonora S, Mahungu T, Owen A, Johnson M, Geretti AM.

    J Antimicrob Chemother. 2008 Dec;62(6):1188-90. Epub 2008 Sep 10.PMID: 18786939 [PubMed - indexed for MEDLINE]Related articles

    17.

    A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease.

    Guaraldi G, Cocchi S, Motta A, Ciaffi S, Codeluppi M, Bonora S, Di Benedetto F, Masetti M, Floridia M, Baroncelli S, Pinetti D, D'Avolio A, Bertolini A, Esposito R.

    J Antimicrob Chemother. 2008 Dec;62(6):1356-64. Epub 2008 Sep 5.PMID: 18776190 [PubMed - indexed for MEDLINE]Related articles

    18.

    A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients.

    D'Avolio A, Sciandra M, Siccardi M, Baietto L, Gonzalez de Requena D, Bonora S, Di Perri G.

    J Chromatogr Sci. 2008 Jul;46(6):524-8. Erratum in: J Chromatogr Sci. 2008 Sep;46(8):8A. PMID: 18647474 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients.

    de Requena DG, Bonora S, Castagna A, Hasson H, Marucco DA, D'Avolio A, Sciandra M, Trentini L, Calcagno A, Lazzarin A, Di Perri G.

    J Antimicrob Chemother. 2008 Aug;62(2):384-7. Epub 2008 May 16.PMID: 18487231 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Does iatrogenic scleroderma due to injection-site reaction to enfuvirtide impair absorption of the drug?

    Maggi P, Filotico R, Bonora S, Volpe A, Bellacosa C, Cinori E, de Requena DG, D'Avolio A, Di Perri G.

    Clin Drug Investig. 2008;28(5):305-11. Review.PMID: 18407716 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    4 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity